Mankind Pharma Limited — Financials & Forensics
Sector: Healthcare · NSE: MANKIND · BSE: 543904 · ISIN: INE634S01028
08 Sep 2026
Add MANKIND to your watchlist — all of this, automated.
Sign in with GoogleAnnual P&L snapshot
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue from operations | ₹8,749 Cr | ₹10,335 Cr | ₹12,207 Cr | ₹14,278 Cr |
| EBITDA | ₹1,901 Cr | ₹2,535 Cr | ₹3,018 Cr | ₹3,617 Cr |
| EBITDA margin | 21.7% | 24.5% | 24.7% | 25.3% |
| Profit after tax | ₹1,282 Cr | ₹1,913 Cr | ₹1,994 Cr | ₹1,913 Cr |
Deeper analysis
Recent filings by Mankind Pharma Limited
-
General Updates
07 Sep 2026 · General Update
-
Please find attached intimation regarding allotment of 49,112 equity shares pursuant to ESOP Plan
01 Sep 2026 · Regulatory Compliance
-
Please find attached transcript of the Investor Conference call for Q1FY27 held on July 30, 2026
04 Aug 2026 · Financial Results
-
Analysts/Institutional Investor Meet/Con. Call Updates
30 Jul 2026 · General Update
-
Press Release
30 Jul 2026 · Financial Results
Never miss a filing again
About Mankind Pharma Limited on Indian Stock Alerts
Indian Stock Alerts tracks Mankind Pharma Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.